SCHEMBL9316477

SCHEMBL9316477

CCCCN(CCCC)C(=O)C(N)CC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA9 Q16790 2/20 0.42
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP8 P22894 1/20 0.40
S1PR1 P21453 2/20 0.40
S1PR2 O95136 1/20 0.40
GPR84 Q9NQS5 4/20 0.39
SLC1A2 P43004 2/20 0.37
SLC1A1 P43005 2/20 0.37
SLC1A3 P43003 1/20 0.37
S1PR3 Q99500 1/20 0.37
GRIK1 P39086 3/20 0.37
GRIK2 Q13002 2/20 0.36
AKR1B1 P15121 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ALDH2 P05091 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9316473 1.00 CA12 (0.42) CA12CA1CA9MMP1MMP2
SCHEMBL7257752 0.93 GPR84 (0.44) S1PR1S1PR2GPR84S1PR3GRIK1
SCHEMBL3806233 0.93 GPR84 (0.44) S1PR1S1PR2GPR84S1PR3GRIK1
SCHEMBL27902175 0.93 GPR84 (0.44) S1PR1S1PR2GPR84S1PR3GRIK1
SCHEMBL7260987 0.93 GPR84 (0.44) S1PR1S1PR2GPR84S1PR3GRIK1
SCHEMBL844867 0.82 DPP4 (0.49) CA12CA1CA9S1PR1S1PR2
SCHEMBL844868 0.82 DPP4 (0.49) CA12CA1CA9S1PR1S1PR2
SCHEMBL17503630 0.80 DPP4 (0.38) S1PR1S1PR2SLC1A2SLC1A1SLC1A3
SCHEMBL2285470 0.79 GABRR1 (0.37) SLC1A2SLC1A1SLC1A3GRIK1GRIK2
SCHEMBL16240308 0.77 DPP4 (0.47) S1PR1S1PR2GPR84SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2813558-B1 GELLING AGENT AJINOMOTO KK (JP) 2018-01-17 EP disclosed
US-9522104-B2 Gelling agent AJINOMOTO CO., INC. (JP) 2016-12-20 US disclosed
CN-104105772-B Gelling agent 味之素株式会社 2016-09-21 CN disclosed
EP-2813558-A1 GELLING AGENT Ajinomoto Co., Inc. (JP) 2014-12-17 EP disclosed
US-20140341960-A1 GELLING AGENT AJINOMOTO CO., INC. (JP) 2014-11-20 US disclosed
EP-0625141-A1 AMINO ACID DERIVATIVES WITH ANTICHOLECYSTOKININ ACTIVITY. BLACK JAMES FOUNDATION (GB) 1994-11-23 EP disclosed
WO-1993014066-A1 AMINO ACID DERIVATIVES WITH ANTICHOLECYSTOKININ ACTIVITY JAMES BLACK FOUNDATION LIMITED (GB) 1993-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140341960-A1 GELLING AGENT CUTA, DEK, SUCLG1 CA12 3869/4885CA1 4077/4885CA9 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.